SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001204459-10-002487
Filing Date
2010-10-21
Accepted
2010-10-21 08:01:09
Documents
26
Period of Report
2010-10-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 6286
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 4511
3 exhibi24.jpg GRAPHIC 38431
4 exhibi1.jpg GRAPHIC 41584
5 exhibi2.jpg GRAPHIC 125542
6 exhibi3.jpg GRAPHIC 97088
7 exhibi4.jpg GRAPHIC 66063
8 exhibi5.jpg GRAPHIC 71478
9 exhibi6.jpg GRAPHIC 90261
10 exhibi7.jpg GRAPHIC 104017
11 exhibi8.jpg GRAPHIC 65007
12 exhibi9.jpg GRAPHIC 86468
13 exhibi10.jpg GRAPHIC 74763
14 exhibi11.jpg GRAPHIC 91793
15 exhibi12.jpg GRAPHIC 62289
16 exhibi13.jpg GRAPHIC 79987
17 exhibi14.jpg GRAPHIC 85052
18 exhibi15.jpg GRAPHIC 80578
19 exhibi16.jpg GRAPHIC 81805
20 exhibi17.jpg GRAPHIC 63477
21 exhibi18.jpg GRAPHIC 69438
22 exhibi19.jpg GRAPHIC 63941
23 exhibi20.jpg GRAPHIC 57771
24 exhibi21.jpg GRAPHIC 79130
25 exhibi22.jpg GRAPHIC 57491
26 exhibi23.jpg GRAPHIC 95625
  Complete submission text file 0001204459-10-002487.txt   2535172
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34236 | Film No.: 101134093
SIC: 2834 Pharmaceutical Preparations